Literature DB >> 15705271

Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy.

J Byakika-Tusiime1, J H Oyugi, W A Tumwikirize, E T Katabira, P N Mugyenyi, D R Bangsberg.   

Abstract

Our objective was to determine the level of adherence and reasons for non-adherence to antiretroviral therapy (ART) among HIV-positive (HIV+) people on ART in a resource-limited setting. Patients receiving ART were recruited into the cross-sectional study from three treatment centres in Kampala, Uganda. The number of missed doses over the last three days was assessed by structured patient interviews and dichotomized at +/-95% adherence. Reasons for non-adherence were assessed with both structured patient interviews and unstructured qualitative interviews. Independent predictors of non-adherence were assessed with multivariate logistic regression. In all, 304 HIV-infected persons on ART were enrolled into the study. Factors associated with non-adherence were marital status (odds ratio (OR) = 2.93, 95% confidence interval (CI) 1.32-6.50) and low monthly income <50 US$ [OR = 2.77, 95% CI 1.64-4.67]. We concluded that levels of self-reported adherence in patients receiving ART in Kampala are comparable to levels in resource-rich settings with inability to purchase and secure a stable supply as a major barrier to adherence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15705271     DOI: 10.1258/0956462052932548

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  73 in total

1.  Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study.

Authors:  Etheldreda Nakimuli-Mpungu; Brian Mutamba; Makanga Othengo; Seggane Musisi
Journal:  Afr Health Sci       Date:  2009-08-01       Impact factor: 0.927

Review 2.  Antiretroviral adherence in a resource-poor setting.

Authors:  Catherine Orrell
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

3.  The price of adherence: qualitative findings from HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda.

Authors:  J T Crane; A Kawuma; J H Oyugi; J T Byakika; A Moss; P Bourgois; D R Bangsberg
Journal:  AIDS Behav       Date:  2006-07

Review 4.  How qualitative methods contribute to understanding combination antiretroviral therapy adherence.

Authors:  Andrea Sankar; Carol Golin; Jane M Simoni; Mark Luborsky; Cynthia Pearson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

5.  Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings.

Authors:  Kartik K Venkatesh; A K Srikrishnan; Kenneth H Mayer; N Kumarasamy; Sudha Raminani; E Thamburaj; Lakshmi Prasad; Elizabeth W Triche; Suniti Solomon; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2010-11-22       Impact factor: 5.078

6.  Determinants of optimal adherence over time to antiretroviral therapy amongst HIV positive adults in South Africa: a longitudinal study.

Authors:  Dikokole Maqutu; Temesgen Zewotir; Delia North; Kogieleum Naidoo; Anneke Grobler
Journal:  AIDS Behav       Date:  2011-10

7.  GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda.

Authors:  Mark J Siedner; Alexander Lankowski; Alexander C Tsai; Conrad Muzoora; Jeffrey N Martin; Peter W Hunt; Jessica E Haberer; David R Bangsberg
Journal:  AIDS       Date:  2013-06-01       Impact factor: 4.177

8.  Reduced adherence to antiretroviral therapy among HIV-infected Tanzanians seeking cure from the Loliondo healer.

Authors:  Nathan M Thielman; Jan Ostermann; Kathryn Whetten; Rachel Whetten; Dafrosa Itemba; Venance Maro; Brian Pence; Elizabeth Reddy
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

9.  Predictors of adherence to antiretroviral therapy in rural Zambia.

Authors:  James G Carlucci; Aniset Kamanga; Robb Sheneberger; Bryan E Shepherd; Cathy A Jenkins; John Spurrier; Sten H Vermund
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-15       Impact factor: 3.731

10.  Alcohol Interactive Toxicity Beliefs and ART Non-adherence Among HIV-Infected Current Drinkers in Mbarara, Uganda.

Authors:  Robin Fatch; Nneka I Emenyonu; Winnie Muyindike; Allen Kekibiina; Sarah Woolf-King; Judith A Hahn
Journal:  AIDS Behav       Date:  2017-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.